BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Zentraxa

Zentraxa logo

Founded
2017
Geography
United Kingdom based
Funding
$0.630 M

Zentraxa has specialise in the design, production and testing of complex novel peptides.


Posts Mentioning This Company

R&D Platform

Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent previously existingbio-design limits imposed by conventional peptide synthesis, with one universal process.


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet